Unsolved problems in the approach to pediatric community-acquired pneumonia

Current Opinion in Infectious Diseases

Volumn 25, Issue 3, 2012, Pages 286-291

  Esposito, Susanna ^a   Principi, Nicola ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

children; community acquired pneumonia; pneumonia; respiratory infection

Indexed keywords

ANTIBIOTIC AGENT;

ANTIBIOTIC THERAPY; CHILD; CHILD HOSPITALIZATION; COMMUNITY ACQUIRED PNEUMONIA; DIAGNOSTIC APPROACH ROUTE; DISEASE SEVERITY; HUMAN; REVIEW; SYMPTOM; TREATMENT DURATION; TREATMENT INDICATION;

ANTI-BACTERIAL AGENTS; CHILD; CHILD, PRESCHOOL; COMMUNITY-ACQUIRED INFECTIONS; HUMANS; INFANT; PNEUMONIA;

EID: 84861097921     PISSN: 09517375     EISSN: 14736527     Source Type: Journal    
DOI: 10.1097/QCO.0b013e328352b60c     Document Type: Review

References (30)

1. Principi N, Esposito S. Management of severe community-acquired pneumonia of children in developing and developed countries. Thorax 2011; 66:815-822. A comprehensive review of pediatric CAP and how to manage possible complications.
2. Harris M, Clark J, Coote N, et al. British Thoracic Society guidelines for the management of community acquired pneumonia in children: Update 2011. Thorax 2011; 66 (Suppl 2):ii1-ii23. Updated guidelines published by the British Thoracic Society on how to diagnose and treat pediatric CAP.
3. Bradley JS, Byington CL, Shah SS, et al. Executive summary: The management of community-acquired pneumonia in infants and children older than 3 months of age - clinical practice guidelines by the Pediatric Infectious Diseases Society and the Infectious Diseases Society of America. Clin Infect Dis 2011; 53:617-630. The first pediatric guidelines on pediatric CAP published by the Pediatric Infectious Diseases Society and the Infectious Diseases Society of America.
4. World Health Organization. Pneumonia. Fact sheet No. 331. 2009. http://www.who.int/mediacentre/factsheets/fs331/en/index.html. [Accessed 7 September 2010]
5. Neuman MI, Monuteaux MC, Scully KJ, Bachur RG. Prediction of pneumonia in a pediatric emergency department. Pediatrics 2011; 128:246-253. An interesting and original study showing how historical and physical examination findings can be used to stratify children at risk of radiographic pneumonia.
6. Bilkis MD, Gorgal N, Carbone M, et al. Validation and development of a clinical prediction rule in clinically suspected community-acquired pneumonia. Pediatr Emerg Care 2010; 26:399-415.
7. Neuman MI, Lee EY, Bixby S, et al. Variability of the interpretation of chest radiographs for the diagnosis of pneumonia in children. J Hosp Med 2011. doi: 10.1002/jkm.955. [Epub ahead of print] A well conducted study showing the variability of pneumonia diagnoses based on radiographic findings.
8. Ayieko P, English M. In children aged 2-59 months with pneumonia, which clinical signs best predict hypoxaemia? J Trop Pediatr 2006; 52:307-310.
9. Fu LY, Ruthazer R, Wilson I, et al. Brief hospitalization and pulse oximetry for predicting amoxicillin treatment failure in children with severe pneumonia. Pediatrics 2006; 118:e1822-e1830.
10. Thompson M, Coad N, Harnden A, et al. How well do vital signs identify children with serious infections in paediatric emergency care? Arch Dis Child 2009; 94:888-893.
11. Flood RG, Badik J, Aronoff SC. The utility of serum C-reactive protein in differentiating bacterial from nonbacterial pneumonia in children: A metaanalysis of 1230 children. Pediatr Infect Dis J 2008; 27:95-99.
12. Khan DA, Rahman A, Khan FA. Is procalcitonin better tha C-reactive protein for early diagnosis of bacterial pneumonia in children? J Clin Lab Anal 2010; 24:1-5. A study comparing the benefits and limitations of procalcitonin and CRP in pediatric CAP.
13. Burkhardt O, Ewig S, Haagen U, et al. Procalcitonin guidance and reduction of antibiotic use in acute respiratory tract infection. Eur Respir J 2010; 36:601-607. An evaluation of the usefulness of procalcitonin in reducing antibiotic use in CAP.
14. De Schutter I, De Wachter E, Crokaert F, et al. Microbiology of bronchoalveolar lavage fluid in children with acute nonresponding or recurrent community- acquired pneumonia: Identification of nontypeable Haemophilus influenzae as a major pathogen. Clin Infect Dis 2011; 52:1437-1444. An interesting study of the cause of acute nonresponding or recurrent CAP using invasive diagnostic methods
15. Shah SS, Dugan MH, Bell LM, et al. Blood cultures in the emergency department evaluation of childhood pneumonia. Pediatr Infect Dis J 2011; 30:475-479. A study showing the limited value of blood cultures in children attending an emergency department because of CAP.
16. Resti M, Micheli A, Moriondo M, et al. Comparison of the effect of antibiotic treatment on the possibility of diagnosing invasive pneumococcal disease by culture or molecular methods: A prospective, observational study of children and adolescents with proven pneumococcal infection. Clin Ther 2009; 31:1266-1273.
17. Resti M, Moriondo M, Cortimiglia M, et al. Community-acquired bacteremic pneumococcal pneumonia in children: Diagnosis and serotyping by real-time polymerase chain reaction using blood samples. Clin Infect Dis 2010; 51:1042-1049. A polymerase chain reaction study of the role of S. pneumoniae in pediatric CAP.
18. Marchese A, Esposito S, Coppo E, et al. Detection of Streptococcus pneumoniae and identification of pneumococcal serotypes by real-time polymerase chain reaction using blood samples from Italian children - 5 years of age with community-acquired pneumonia. Microb Drug Resist 2011; 17:419-424. An interesting study showing the benefits of real-time polymerase chain reaction over traditional cultures of blood samples in etiologically identifying pneumococcal CAP in children.
19. Lahti E, Peltola V, Waris M, et al. Induced sputum in the diagnosis of childhood community-acquired pneumonia. Thorax 2009; 64:252-257.
20. Thurman KA, Walter ND, Schwartz SB, et al. Comparison of laboratory diagnostic procedures for detection of Mycoplasma pneumoniae in community outbreaks. Clin Infect Dis 2009; 48:1244-1249.
21. Jansen RR, Wieringa J, Koekkoek SM, et al. Frequent detection of respiratory viruses without symptoms: Toward defining clinically relevant cutoff values. J Clin Microbiol 2011; 49:2631-2636. An interesting study showing that respiratory viruses can also be frequently detected in healthy children.
22. Morens DM, Taubenberger JK, Fauci AS. Predominant role of bacterial pneumonia as a cause of death in pandemic influenza: Implications for pandemic influenza preparedness. J Infect Dis 2008; 198:962-970.
23. Randolph AG, Vaughn F, Sullivan R, et al. Critically ill children during the 2009-2010 influenza pandemic in the United States. Pediatrics 2001; 128:e1450-e1458.
24. Levin D, Tribuzio M, Green-Wrzesinki T, et al. Empiric antibiotics are justified for infants with respiratory syncytial virus lower respiratory tract infection presenting with respiratory failure: A prospective study and evidence review. Pediatr Crit Care Med 2010; 11:390-395.
25. Don M, Valent F, Korppi M, Canciani M. Differentiation of bacterial and viral community-acquired pneumonia in children. Pediatr Int 2009; 51:91-96.
26. Esposito S, Daleno C, Prunotto G, et al. Impact of viral infections in children with community-acquired pneumonia: Results of a study of 17 respiratory viruses. Influenza Other Resp Viruses 2012. doi:10.1111/j.1750-2659.2012. 00340.x. [Epub ahead of print] This study highlights the importance of respiratory viruses (mainly RSV and rhinovirus) in children with CAP, and describes the characteristics of the single infections and coinfections associated with the disease.
27. Esposito S, Daleno C, Tagliabue C, et al. Impact of rhinoviruses on pediatric community-acquired pneumonia. Eur J Clin Microbiol Infect Dis 2011. [Epub ahead of print] A study of the characteristics of CAP associated with infections due to different types of rhinovirus.
28. US Department of Health and Human Services Food and Drug Administration, Center for Drug Evaluation and Research. Guidance for industry. Communityacquired bacterial pneumonia: Developing drugs for treatment. 2009. http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/ Guidances/ucm123686.pdf. [Accessed 7 September 2010]
29. Esposito S, Tagliabue C, Picciolli I, et al. Procalcitonin measurements for guiding antibiotic treatment in pediatric pneumonia. Respir Med 2011; 105:1939-1945. The results of this first prospective study using a procalcitonin cutoff value to guide antibiotic therapy for pediatric CAP showed that this approach can significantly reduce antibiotic use and antibiotic-related adverse events in children with uncomplicated disease.
30. Haider BA, Saeed MA, Bhutta ZA. Short-course versus long-course antibiotic therapy for nonsevere community-acquired pneumonia in children aged 2 months to 59 months. Cochrane Database Syst Rev 2008; 16:CD005976.